A homegrown biotech success storyPublished: Sunday, November 24, 2019 By: Dr. Stephen Prescott Source: NewsOK
When Novartis announced earlier this month that the U.S. Food and Drug Administration had approved the company’s new drug to treat sickle cell anemia, the press release didn’t mention Oklahoma. But it should have.
That drug, known as Adakveo, is as Oklahoman as redbuds and scissor-tailed flycatchers. Indeed, but for work done in our state over several decades, it wouldn’t exist.
The story begins with Dr. Rodger McEver.
McEver came to Oklahoma in 1988, establishing a lab at the Oklahoma Medical Research Foundation. His research focused on white blood cells. Specifically, he studied a protein known as P-selectin, which mobilizes white blood cells to hunt down and stop invaders like bacteria in the body.
Read the story on NewsOK.com.